BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28598202)

  • 1. Evaluation of the effect of time dependent dosing on pharmacokinetic and pharmacodynamics of amlodipine in normotensive and hypertensive human subjects.
    Khodadoustan S; Nasri Ashrafi I; Vanaja Satheesh K; Kumar C; Hs S; S C
    Clin Exp Hypertens; 2017; 39(6):520-526. PubMed ID: 28598202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study.
    Kasiakogias A; Tsioufis C; Thomopoulos C; Andrikou I; Aragiannis D; Dimitriadis K; Tsiachris D; Bilo G; Sideris S; Filis K; Parati G; Stefanadis C
    J Hypertens; 2015 Feb; 33(2):393-400. PubMed ID: 25318654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate.
    Qiu YG; Chen JZ; Zhu JH; Yao XY
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):335-41. PubMed ID: 14618095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats.
    Potucek P; Radik M; Doka G; Kralova E; Krenek P; Klimas J
    Clin Exp Hypertens; 2017; 39(8):754-763. PubMed ID: 28665713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing.
    Hermida RC; Ayala DE; Fontao MJ; Mojón A; Fernández JR
    Chronobiol Int; 2010 Jul; 27(6):1287-303. PubMed ID: 20653455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of daily anti-hypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring - utility of "hypobaric curve" and "hypobaric area".
    Kuga K; Xu DZ; Ohtsuka M; Aonuma K; Lau AH; Watanabe Y; Ohtsuka K
    Clin Exp Hypertens; 2011; 33(4):231-9. PubMed ID: 21699449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
    Lemmer B
    Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population.
    Kawabe H; Saito I; Saruta T
    Hypertens Res; 2005 Jun; 28(6):491-8. PubMed ID: 16231754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine.
    Asmar R; Gosse P; Queré S; Achouba A
    Blood Press Monit; 2011 Apr; 16(2):80-6. PubMed ID: 21372694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympatho-excitatory responses to once-daily dihydropyridines in young versus older hypertensive patients: amlodipine versus felodipine extended release.
    Leenen FH; Coletta E; White R
    J Hypertens; 2006 Jan; 24(1):177-84. PubMed ID: 16331116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amlodipine once or twice daily on circadian blood pressure profile, myocardial hypertrophy, and beta-adrenergic signaling in transgenic hypertensive TGR(mREN2)27 rats.
    Witte K; Schnecko A; Voll C; Schmidt T; Lemmer B
    J Cardiovasc Pharmacol; 1998 May; 31(5):661-8. PubMed ID: 9593064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of combination antihypertensive therapy on circadian blood pressure and metabolic parameters in patients with type 2 diabetes mellitus].
    Statsenko ME; Derevianchenko MV; Pastukhova OR
    Kardiologiia; 2014; 54(11):20-4. PubMed ID: 25902654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and 24-h blood pressure profile of amlodipine monotherapy.
    Ibrahim MM; el-Boghdadly B; Zaghloul SS
    J Hum Hypertens; 1996 Jul; 10(7):489-94. PubMed ID: 8880565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period.
    White WB; Lacourciere Y; Davidai G
    Am J Hypertens; 2004 Apr; 17(4):347-53. PubMed ID: 15062889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening.
    Mengden T; Binswanger B; Spühler T; Weisser B; Vetter W
    J Hypertens; 1993 Dec; 11(12):1403-11. PubMed ID: 8133022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapy.
    Yoshida H; Akasaka H; Saitoh S; Shimamoto K; Miura T;
    Hypertens Res; 2014 Mar; 37(3):225-31. PubMed ID: 24108237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circadian rhythm of arterial pressure and use of amlodipine in primary hypertension].
    Spritzer N
    Arq Bras Cardiol; 1993 May; 60(5):361-7. PubMed ID: 8311755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F;
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.